i2TRON is a highly innovative PhD training program on integrating immune strategies for Translational Research in Oncology and Neurology and is supported by the Luxembourg National Research Fund (FNR) within their PRIDE program.
We will develop the next generation of translational scientists as boundary crossers, domain experts and skilled communicators.
Inflammation is a common hallmark shared across different non-communicable diseases (NCD).
i 2 TRON aims to advance our mechanistic insight into failures of the immune system across diverse disease areas including cancer, neurodegeneration, autoimmunity and allergy.
Such insights will lead to discoveries of new biomarkers and therapeutic targets of NCDs, and facilitate translation into novel treatment strategies to advance research innovations, and to turn new mechanistic insight into diagnostic and therapeutic strategies to improve patient care.
What we expect from you
We are seeking excellent and highly motivated candidates holding a Master’s degree (MSc or equivalent) in a field related to the topics of the PhD program interested in becoming a translational scientist at the interface between fundamental and clinical research.
Advanced English knowledge in spoken and written is required, as English is the working language.
Earliest start date will be July 15th, 2021 after a comprehensive and competitive selection process starting in June 2021.
includes individualized transferable skills training, career development programs, opportunities for international conference visits, internships in partner institutions regular scientific lectures by leading international speakers and annual PhD retreats.
PhD candidates will conduct their research projects in a highly interdisciplinary environment at either LIH or UL. All PhD candidates will be enrolled at the University of Luxembourg.
The program will allow the candidates to obtain a PhD degree in Systems and Molecular Biomedicine or Health Science.